ORIC Pharmaceuticals increases inducement equity plan share reserve by 1.1M shares to 3.35M total

Oric Pharmaceuticals, Inc.

Board approved Amended and Restated 2022 Inducement Plan, adding 1,100,000 shares of common stock.
Total shares reserved under the plan now 3,350,000 for equity awards to new employees.
Plan allows grants of nonstatutory stock options, RSUs, SARs, performance shares/units.
Adopted without stockholder approval per Nasdaq Listing Rules as inducement grants.
Plan terms are substantially similar to the company's 2020 Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.